176 related articles for article (PubMed ID: 2145256)
21. The post-antibiotic effects of linezolid against Gram-positive pathogens.
Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S
Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
[TBL] [Abstract][Full Text] [Related]
23. The bactericidal activity of vancomycin and teicoplanin against methicillin-resistant strains of coagulase negative Staphylococcus spp.
O'Hare MD; Felmingham D; Grüneberg RN
J Antimicrob Chemother; 1989 May; 23(5):800-2. PubMed ID: 2527220
[No Abstract] [Full Text] [Related]
24. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Feb; 6(1):96-9. PubMed ID: 3032613
[TBL] [Abstract][Full Text] [Related]
26. [Recent trend and development of novel antimicrobial agents for MRSA infections].
Nishino T
Nihon Rinsho; 1992 May; 50(5):1066-74. PubMed ID: 1324332
[TBL] [Abstract][Full Text] [Related]
27. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
Biavasco F; Giovanetti E; Montanari MP; Lupidi R; Varaldo PE
J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
[TBL] [Abstract][Full Text] [Related]
28. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility of gram-positive cocci to paldimycin.
Pohlod DJ; Saravolatz LD; Somerville MM
Antimicrob Agents Chemother; 1987 Jan; 31(1):104-7. PubMed ID: 3105438
[TBL] [Abstract][Full Text] [Related]
30. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
[TBL] [Abstract][Full Text] [Related]
32. In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin.
Watanakunakorn C
J Antimicrob Chemother; 1990 Jan; 25(1):69-72. PubMed ID: 2138602
[TBL] [Abstract][Full Text] [Related]
33. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
Maple PA; Hamilton-Miller JM; Brumfitt W
J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
35. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
Barry AL; Jones RN; Gavan TL; Thornsberry C
J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
Kenny MT; Dulworth JK; Brackman MA
Diagn Microbiol Infect Dis; 1991; 14(1):29-31. PubMed ID: 1826479
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin].
Młynarczyk G; Młynarczyk A; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1995; 47(3-4):133-9. PubMed ID: 8833924
[TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Drago L; De Vecchi E; Nicola L; Gismondo MR
BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.
Blenkharn JI; Darrell JH
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):734-7. PubMed ID: 2550236
[TBL] [Abstract][Full Text] [Related]
40. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Huang YT; Liao CH; Teng LJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
